COVID-19 outbreak impact on urolithiasis treatments: A multicenter retrospective study across 9 urological centers in Italy

• Published in: Current urology Vol. 18; no. 4; pp. 301 - 306
• Main Authors: Mazzon, Giorgio, Ferretti, Stefania, Serafin, Emanuele, Claps, Francesco, Acquati, Pietro, Brusa, Davide, Germinale, Federico, Celentano, Giuseppe, Pescuma, Andrea, Fugini, Andrea Vismara, Campobasso, Davide, Maestroni, Umberto, Costa, Giovanni, Morena, Tonino, Di Marco, Flavia, Baudo, Andrea, Creta, Massimiliano, Pavan, Nicola, Ticonosco, Marco, Peroni, Angelo, Collura, Devis, Cerruto, Maria Angela, Antonelli, Alessandro, Carmignani, Luca, Micali, Salvatore, Trombetta, Carlo, Muto, Giovanni, Celia, Antonio
• Format: Journal Article
• Language: English
• Published: United States Lippincott Williams & Wilkins 01.12.2024; Wolters Kluwer Health
• Subjects: Original; Special Topic: Advances in Urolithiasis Treatment; COVID-19; Retrograde intrarenal surgery; Extracorporeal shock wave lithotripsy; Urolithiasis; Percutaneous nephrolithotomy
• ISSN: 1661-7649; 1661-7657
• DOI: 10.1097/CU9.0000000000000246

Abstract Background The coronavirus disease (COVID-19) pandemic has posed challenges to the global health care community, affecting the management of upper urinary tract stones. Materials and methods This retrospective study involved 9 Italian centers. We compared the 12-month period prior to COVID-19 (March 1, 2019, to February 28, 2020; Period A) with the COVID-19 period (March 1, 2020, to February 28, 2021, Period B). This study aimed to compare outcomes during Periods A and B, specifically focusing on the overall number of treatments, rate of urgent/elective cases, and operational complexity. Results A total of 4018 procedures were collected, comprising 2176 procedures during Period A and 1842 during Period B, indicating a loss of 15.35% (p < 0.001). In the elective cases, 1622 procedures were conducted in Period A, compared with 1280 in Period B, representing a 21.09% reduction in cases (p = 0.001). All types of stone treatments were affected: extracorporeal shock wave lithotripsy (−29.37%, p = 0.001), percutaneous nephrolithotomy (−26.47%, p = 0.008), retrograde surgeries for renal stones (−10.63%, p = 0.008), and semirigid ureterolithotripsy (−24.86%, p = 0.008). Waiting lists experienced significant delays during Period B. The waiting time (WT) for elective procedures increased during Period B (p < 0.001). For ureteral stones, the mean WT in Period A was 61.44 days compared with 86.56 days in Period B (p = 0.008). The WT for renal stones increased from 64.96 days in Period A to 85.66 days in Period B for retrograde intrarenal surgery (p = 0.008) and from 96.9 days to 1103.9 days (p = 0.035) for percutaneous nephrolithotomy procedures. Conclusions Our study demonstrates that COVID-19 significantly disrupted endourological services across the country. Our data underline how patients received treatment over a prolonged period, potentially increasing the risk of stone-related complications and patient discomfort.